eMedevents
  • 146,967+ Medical Conferences
  • 284 Specialties
  • 10,935 Organizers
  • 154,888 Speakers
  • 156 Countries
  • 4,693 Cities
48,989+
CME Conference Registrations Sold
Home  >  Speakers  >  James F. Smothers
James F. Smothers

James F. Smothers

    PhD
Senior Director | Philadelphia, Pennsylvania    United States Of America
Oncology, Precision Oncology Medicine
Oncology, Immunofluorescence Assays,...More
Spoken at 1 event

Biography :

James’ first experience with antibodies was during his undergraduate studies at the University of Missouri, Columbia where he conducted immunofluorescence assays for veterinary pathologists. He later developed several novel antibodies and applications to support both his graduate and post-doctoral research of heterochromatin dynamics and epigentics at the University of Rochester and the Fred Hutchinson Cancer Research Center, respectively. In 2001, James accepted a position in Discovery Research at Immunex which was later acquired by Amgen. At both Immunex and Amgen, James led several therapeutic antibody programs to treat cancer, inflammation and metabolic disease. He is a named inventor on multiple patents and applications which correspond to monoclonal antibodies in Amgen’s pipeline. James joined the Oncology R&D unit at GlaxoSmithKline in 2010. In his current role, he manages development of therapeutic antibodies and related biopharmaceuticals in partnership with GSK’s Biopharm R&D organization.

**********************
**********
 
For speaker's contact information - Contact us

Specialties

Oncology, Precision Oncology medicine

Interested Topics

Oncology, Immunofluorescence assays, Heterochromatin dynamics, Epigentics, Therapeutic antibody, Inflammation disease, Metabolic disease, Monoclonal antibodies

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message